ZEMPLAR Safety Questions, ZEMPLAR Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ZEMPLAR. Our extensive database of ZEMPLAR adverse events and ZEMPLAR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ZEMPLAR

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




ZEMPLAR Safety Reports

Total ZEMPLAR reports: 250.
ZEMPLAR FDA safety alerts: No.
Reported deaths: 100    Reported hospitalizations: 194.
Take ZEMPLAR Side Effects Survey or Share Your ZEMPLAR Story. ZEMPLAR Usage.

Showing 1-75 of 250 Next >

Physician from GERMANY reported ZEMPLAR problem on Apr 25, 2007. Male patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: coronary angioplasty, stent placement. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from AUSTRIA on May 02, 2007. Female patient, 66 years of age, weighting 246.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: sepsis, vascular bypass graft. ZEMPLAR dosage: unknown. During the same period patient was treated with ANTIPHOS, ALFACALCIDOL. Patient died on 04/09/2006.

Physician from GREECE reported ZEMPLAR problem on May 02, 2007. Male patient, 82 years of age, weighting 176.4 lb, was diagnosed with hyperparathyroidism secondary, coronary artery disease, anaemia, blood phosphorus abnormal and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: anaemia, faeces discoloured, thrombocytopenia. ZEMPLAR dosage: unknown. During the same period patient was treated with CARVEDILOL, EPOETIN ALFA, CLOPIDOGREL BISULPHATE, FOLIC ACID, TITRALAC, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from CZECH REPUBLIC on Apr 30, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, angina pectoris, coronary artery disease, dyspnoea, full blood count decreased, left ventricular failure, occult blood positive, supraventricular tachycardia. ZEMPLAR dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Physician from GREECE reported ZEMPLAR problem on May 02, 2007. Female patient, 62 years of age, weighting 137.8 lb, was diagnosed with hyperparathyroidism secondary, anaemia, carnitine decreased, vitamin supplementation, peripheral vascular disorder, coronary artery disease, hyperphosphataemia and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: gangrene, pneumonia. ZEMPLAR dosage: unknown. During the same period patient was treated with EPOETIN BETA, INTELLECTA, CERNEVIT, BUFLOMEDIL HYDROCHLORIDE, ACETYLSALICYLIC ACID SRT, FORSENOL. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from UNITED STATES on May 02, 2007. Female patient, weighting 88.18 lb, was diagnosed with glomerulonephritis, hyperparathyroidism and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, cardiac failure congestive, cardio-respiratory arrest, gastroenteritis, hepatitis cholestatic, hypertension, renal failure chronic. ZEMPLAR dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, ISOSORBIDE MONONITRATE, AMLODIPINE BESYLATE, LABETALOL, QUININE SULPHATE. Patient was hospitalized. Patient died on 10/25/2005.

Physician from AUSTRIA reported ZEMPLAR problem on May 02, 2007. Female patient, weighting 166.4 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiac failure. ZEMPLAR dosage: unknown. During the same period patient was treated with NYCOC, DIGITOXIN, MOLSIDOMINE, FUROSEMIDE, ACETYLSALICYLIC ACID SRT, CLOPIDOGREL BISULPHATE. Patient died on 03/27/2007.

ZEMPLAR problem was reported by a Physician from GREECE on May 02, 2007. Male patient, 69 years of age, weighting 132.3 lb, was diagnosed with hyperparathyroidism secondary, anaemia, blood phosphorus abnormal, coronary artery disease, hyperlipidaemia and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, haematuria, renal colic. ZEMPLAR dosage: unknown. During the same period patient was treated with EPOETIN BETA, TITRALAC, CLOPIDOGREL BISULPHATE, METOPROLOL TARTRATE, INEVY. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on May 07, 2007. Female patient, weighting 121.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: coronary artery disease, duodenal ulcer, gastrointestinal haemorrhage, peripheral arterial occlusive disease, wound dehiscence. ZEMPLAR dosage: unknown. During the same period patient was treated with GASTAL, CALCIUM CARBONATE, THEOPHYLLINE, SPIRIVA, FRAGMIN PTE, EPOGEN. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on May 11, 2007. Male patient, 83 years of age, weighting 185.2 lb, was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: fall, haematoma, hypercalcaemia, shunt thrombosis, skin laceration. ZEMPLAR dosage: unknown. During the same period patient was treated with ATACANT, PANTOPRAZOLE, VITARENAL, CARBIDOPA, PRIMIDONE, ERYPOETIN, ATRAPHANA, ALFACALCIDOL. Patient was hospitalized. Patient recovered.

Physician from GREECE reported ZEMPLAR problem on May 16, 2007. Female patient, 62 years of age, weighting 137.8 lb, was diagnosed with hyperparathyroidism secondary, anaemia, carnitine decreased, vitamin supplementation, peripheral vascular disorder, coronary artery disease, hyperphosphataemia and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: gangrene, pneumonia. ZEMPLAR dosage: unknown. During the same period patient was treated with EPOETIN BETA, INTELLECTA, CERNEVIT, BUFLOMEDIL HYDROCHLORIDE, ACETYLSALICYLIC ACID SRT, FORSENOL. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on May 23, 2007. Male patient, 83 years of age, weighting 185.2 lb, was diagnosed with diabetic neuropathy, dialysis and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: fall, haematoma, hypercalcaemia, shunt thrombosis, skin laceration. ZEMPLAR dosage: unknown. During the same period patient was treated with ATACANT, PANTOPRAZOLE, VITARENAL, CARBIDOPA, PRIMIDONE, ERYPOETIN, ATRAPHANA. Patient was hospitalized. Patient recovered.

Physician from GREECE reported ZEMPLAR problem on May 22, 2007. Female patient, 57 years of age, weighting 187.4 lb, was diagnosed with hyperparathyroidism secondary, anaemia, unevaluable event, blood phosphorus abnormal and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, gastroenteritis, vomiting. ZEMPLAR dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, TICLOPIDINE HYDROCHLORIDE, MAGNESIUM SULPHATE, MAGNESIUM SULPHATE, FOLIC ACID, TITRALAC. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from CZECH REPUBLIC on May 31, 2007. Female patient, weighting 174.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: arteriovenous shunt operation, cellulitis, cerebrovascular accident, diabetic gangrene, femoral arterial stenosis, hepatitis a, hepatitis infectious, inflammation, myocardial infarction. ZEMPLAR dosage: unknown. During the same period patient was treated with ACIDUM FOLICUM, AGAPURIN RETARD, COXTRAL, DIAZEPAM, BISULEPIN HYDROCHLORIDE, FERRIC GLUCONATE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on May 30, 2007. Female patient, 73 years of age, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: hospitalisation. ZEMPLAR dosage: unknown. During the same period patient was treated with CALCIUM ACETATE, CALCIUM ACETATE, COLECALCIFEROL, MIMPARA, METOPROLOL SUCCINATE, MOXONIDINE. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from CZECH REPUBLIC on May 30, 2007. Female patient, weighting 147.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary, thrombosis prophylaxis, hyperphosphataemia, depression, anaemia and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: breast cancer, breast discomfort, breast disorder, dyspnoea, hydrothorax, metastases to liver, metastases to lymph nodes, pleural effusion, skin ulcer. ZEMPLAR dosage: unknown. During the same period patient was treated with FUROSEMIDE, TICLOPIDINE HYDROCHLORIDE, MIMPARA, SEVELAMER HYDROCHLORIDE, TIANEPTINE, NADROPARIN CALCIUM, EPOETIN ALFA. Patient was hospitalized. Patient died on 05/28/2007.

Physician from GERMANY reported ZEMPLAR problem on May 30, 2007. Male patient, weighting 194.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: nausea, pulmonary embolism, vomiting. ZEMPLAR dosage: unknown. During the same period patient was treated with CALCIUM ACETATE, COLECALCIFEROL, CARVEDILOL, TORSEMIDE, BICARBONATE, ACETYLSALICYLIC ACID SRT, DREISAVIT. Patient died on 01/23/2007.

ZEMPLAR problem was reported by a Physician from GERMANY on June 04, 2007. Female patient, 73 years of age, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: hydrocephalus, intracranial pressure increased. ZEMPLAR dosage: unknown. During the same period patient was treated with CALCIUM ACETATE, CALCIUM ACETATE, COLECALCIFEROL, MIMPARA, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on June 05, 2007. Female patient, weighting 121.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: coronary artery disease, duodenal ulcer, gastrointestinal haemorrhage, peripheral arterial occlusive disease, wound dehiscence. ZEMPLAR dosage: unknown. During the same period patient was treated with GASTAL, CALCIUM CARBONATE, THEOPHYLLINE, SPIRIVA, FRAGMIN PTE, EPOGEN. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from CZECH REPUBLIC on June 15, 2007. Male patient, weighting 135.6 lb, was diagnosed with renal osteodystrophy, cardiovascular event prophylaxis, musculoskeletal pain, hyperphosphataemia, hypertension and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: back pain, body temperature increased, c-reactive protein increased, gastroenteritis, hypercalcaemia, left ventricular dysfunction, movement disorder, musculoskeletal pain, spinal osteoarthritis. ZEMPLAR dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, COXTRAL, SEVELAMER HYDROCHLORIDE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.

Physician from TURKEY reported ZEMPLAR problem on June 19, 2007. Female patient, weighting 121.3 lb, was diagnosed with hyperparathyroidism secondary, anaemia, hyperphosphataemia, prolactinoma, arteriosclerosis and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: dizziness, headache, vomiting, weight decreased. ZEMPLAR dosage: unknown. During the same period patient was treated with SACCHARATED IRON OXIDE, PHOSEX, DASTINIX, CORASPIRIN, EPOETIN ALFA. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on June 21, 2007. Male patient, weighting 176.4 lb, was diagnosed with hyperparathyroidism and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: cardiac failure. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on June 27, 2007. Female patient, 72 years of age, was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: leg amputation. ZEMPLAR dosage: unknown. Patient died.

ZEMPLAR problem was reported by a Physician from CZECH REPUBLIC on June 26, 2006. Female patient, weighting 146.6 lb, was diagnosed with hyperparathyroidism, hypertension, renal failure chronic, platelet aggregation inhibition and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: disorientation, hemiplegia, ischaemic stroke, paresis, syncope, vertigo. ZEMPLAR dosage: unknown. During the same period patient was treated with ENALAPRIL, FUROSEMIDE, ASCORUTIN, ACETYLSALICYLIC ACID SRT, NITRENDIPINE, TELMISARTAN, SEVELAMER HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.

Physician from AUSTRIA reported ZEMPLAR problem on Apr 11, 2006. Male patient, 74 years of age, weighting 200.6 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: infection, osteomyelitis, skin ulcer. ZEMPLAR dosage: unknown. During the same period patient was treated with ANTIPHOSPHATE, CALCITRIOL. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from COLOMBIA on July 06, 2006. Male patient, 74 years of age, weighting 105.4 lb, was diagnosed with hyperparathyroidism secondary, hypertension, gastritis, coronary artery disease, prophylaxis and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. ZEMPLAR dosage: unknown. During the same period patient was treated with PRAZOSIN, OMEPRAZOLE, METOPROLOL TARTRATE, METOPROLOL TARTRATE, ENALAPRIL MALEATE, ENALAPRIL MALEATE, CALCIUM CARBONATE. Patient died on 06/06/2006.

Physician from VENEZUELA reported ZEMPLAR problem on Feb 10, 2006. Female patient, 59 years of age, was diagnosed with hyperparathyroidism secondary, hypertension, vitamin supplementation, anaemia, diabetes mellitus and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: gastric ulcer haemorrhage, upper gastrointestinal haemorrhage. ZEMPLAR dosage: 15MCG/3ML. During the same period patient was treated with LOSARTAN POTASSIUM, FOLIC ACID, VITAMIN, EPOGEN, ACETYLSALICYLIC ACID SRT, ISOPHANE INSULIN. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Apr 08, 2006. Male patient, weighting 163.1 lb, was diagnosed with secondary hypertension, renal failure chronic and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, stenosis of vesicourethral anastomosis, subileus. ZEMPLAR dosage: unknown. During the same period patient was treated with CALCIUM ACETATE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on Apr 06, 2006. Female patient, weighting 121.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: peripheral arterial occlusive disease. ZEMPLAR dosage: unknown. During the same period patient was treated with GASTAL, CALCIUM CARBONATE, THEOPHYLLINE, SPIRIVA, FRAGMIN PTE, EPOGEN, FERRUM. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from CZECH REPUBLIC on June 26, 2006. Female patient, weighting 146.6 lb, was diagnosed with hyperparathyroidism, hypertension, renal failure chronic, platelet aggregation inhibition and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, blood pressure increased, cardiomegaly, cerebral atrophy, depressed mood, disorientation, fistula, hemiplegia, ischaemic stroke. ZEMPLAR dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, FUROSEMIDE, ASCORUTIN, ACETYLSALICYLIC ACID SRT, NITRENDIPINE, TELMISARTAN, SEVELAMER HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on July 15, 2006. Male patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: hypertensive crisis. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on July 15, 2006. Male patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: hypertensive crisis. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from SWITZERLAND reported ZEMPLAR problem on July 20, 2006. Female patient, 80 years of age, weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: asthenia, fall, gait disturbance, hypercalcaemia, malaise. ZEMPLAR dosage: unknown. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on July 15, 2006. Male patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: hypertensive crisis, refusal of treatment by patient, renal artery stenosis. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on May 31, 2006. Male patient, weighting 158.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: angina pectoris, peripheral vascular disorder. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from AUSTRIA on July 12, 2006. Female patient, 67 years of age, weighting 163.1 lb, was diagnosed with hyperparathyroidism secondary, hyperphosphataemia, hypothyroidism, diabetes mellitus, gastritis, coronary artery disease and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia. ZEMPLAR dosage: unknown. During the same period patient was treated with ALFACALCIDOL, SEVELAMER HYDROCHLORIDE, ANTIPHOSPHAT, LEVOTHYROXINE, REPAGLINIDE, PANTOPRAZOLE. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on July 31, 2006. Male patient, weighting 172.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: shunt malfunction. ZEMPLAR dosage: unknown. During the same period patient was treated with ALFACALCIDOL, CALCIUM ACETATE, EPOETIN BETA, DREISAVIT, OMEPRAZOLE, GODAMEND. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from AUSTRIA on Aug 01, 2006. Male patient, 65 years of age, weighting 167.6 lb, was diagnosed with hyperparathyroidism secondary, anaemia, hyperphosphataemia, renal transplant, hypertension and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: parathyroid tumour benign. ZEMPLAR dosage: unknown. During the same period patient was treated with FERRIC GLUCONATE, EPOETIN ALFA, ALUMINIUM HYDROXIDE GEL, CYCLOSPORINE, LISINOPRIL, BISOPROLOL FUMARATE, SEVELAMER HYDROCHLORIDE. Patient recovered.

Health Professional from UNITED STATES reported ZEMPLAR problem on Aug 03, 2006. Female patient, weighting 88.18 lb, was diagnosed with glomerulonephritis and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cardiac failure congestive. ZEMPLAR dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, ISOSORBIDE MONONITRATE, AMLODIPINE BESYLATE, LABETALOL, QUININE SULPHATE, BICARBONATE, CLONIDINE, LOSARTAN POTASSIUM. Patient was hospitalized. Patient died on 10/25/2005.

ZEMPLAR problem was reported by a Physician from AUSTRIA on June 01, 2006. Male patient, 55 years of age, weighting 299.8 lb, was diagnosed with hyperparathyroidism secondary, hyperphosphataemia and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: calcinosis, hyperphosphataemia. ZEMPLAR dosage: unknown. During the same period patient was treated with ALUMINIUM HYDROXIDE GEL, ALUMINIUM HYDROXIDE GEL, SEVELAMER HYDROCHLORIDE, SEVELAMER HYDROCHLORIDE, CALCITRIOL, MIMPARA. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on May 22, 2006. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: electrolyte imbalance, hepatitis alcoholic, incisional hernia. ZEMPLAR dosage: unknown. During the same period patient was treated with POLYBION, ORNIDAZOLE, ALUMINIUM CHLORHYDROXIDE, ALUMINIUM CHLORHYDROXIDE, AMLODIPINE BESYLATE, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Aug 04, 2006. Female patient, weighting 108.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: fall. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on Aug 05, 2006. Male patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: shunt occlusion. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Aug 04, 2006. Male patient, weighting 165.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter sepsis, cough, pseudomonas infection, streptococcal infection, urinary tract infection. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on Aug 07, 2006. Female patient, 35 years of age, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: shunt occlusion. ZEMPLAR dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Aug 09, 2006. Male patient, 71 years of age, weighting 179.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. ZEMPLAR dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, CALCIUM ACETATE, PANTOPRAZOLE, CELIPROLOL HYDROCHLORIDE, NITRENDIPINE, SIMVABETA, FUROSEMIDE, BICANORM. Patient died on 05/22/2006.

Physician from GERMANY reported ZEMPLAR problem on Apr 08, 2006. Male patient, weighting 163.1 lb, was diagnosed with hyperparathyroidism secondary, renal failure chronic and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, stenosis of vesicourethral anastomosis, subileus. ZEMPLAR dosage: unknown. During the same period patient was treated with CALCIUM ACETATE. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Aug 09, 2006. Male patient, 65 years of age, weighting 156.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: shunt occlusion. ZEMPLAR dosage: unknown. During the same period patient was treated with ALUMINIUM CHLORHYDROXIDE, SEVELAMER HYDROCHLORIDE, BICANORM, ALFACALCIDOL. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on Aug 11, 2006. Male patient, weighting 183.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood calcium increased, blood phosphorus increased. ZEMPLAR dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, ACETYLSALICYLIC ACID SRT. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Aug 11, 2006. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood parathyroid hormone increased, blood phosphorus increased, cardiac failure, pulmonary congestion, shock, unevaluable event. ZEMPLAR dosage: unknown. During the same period patient was treated with FUROSEMIDE, ALUMINIUM HYDROXIDE GEL, VERAPAMIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 05/12/2006.

Consumer or non-health professional from UNITED STATES reported ZEMPLAR problem on Aug 11, 2006. Female patient, weighting 95.09 lb, was diagnosed with dementia alzheimer's type, depression, vitamin supplementation and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ZEMPLAR dosage: unknown. During the same period patient was treated with DONEPEZIL HYDROCHLORIDE, BUPROPION, SETRALINE, CALCIUM D, POTASSIUM CHLORIDE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Aug 14, 2006. Male patient, 70 years of age, weighting 160.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, muscle spasms, transplant evaluation. ZEMPLAR dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, MAGNESIUM, PHENPROCOUMON, ESOMEPRAZOLE MAGNESIUM, AMLODIPINE BESYLATE, ALLOPURINOL, AQUAPHOR. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on Aug 04, 2006. Male patient, weighting 165.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter sepsis, cough, pseudomonas infection, streptococcal infection, urinary tract infection. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Aug 15, 2006. Male patient, 64 years of age, weighting 205.0 lb, was diagnosed with hyperparathyroidism and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: shunt malfunction. ZEMPLAR dosage: unknown. During the same period patient was treated with LAXOFALK, ZINC SULPHATE, ALFACALCIDOL, SEVELAMER HYDROCHLORIDE, TORSEMIDE, PANTOPRAZOLE, DREISAVIT N. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on Aug 16, 2006. Female patient, weighting 134.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: skin ulcer, vascular bypass graft. ZEMPLAR dosage: unknown. During the same period patient was treated with PHOS EX, DECOSTRIOL, FUROSEMIDE, CYCLOSPORINE, ACETYLSALICYLIC ACID SRT, FAMOTIDINE, PREDNISONE, VISKEN MITE. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from SPAIN on Aug 15, 2006. Male patient, 77 years of age, was diagnosed with hyperparathyroidism secondary, anaemia and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dyspnoea. ZEMPLAR dosage: unknown. During the same period patient was treated with ACENOCOUMAROL, CALCIUM ACETATE, DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 08/13/2006.

Physician from GERMANY reported ZEMPLAR problem on Aug 17, 2006. Female patient, weighting 169.8 lb, was diagnosed with hyperparathyroidism secondary, arrhythmia, gastritis, diabetes mellitus and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: fall, fracture. ZEMPLAR dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, PANTOPRAZOLE, SIVMAHEXAL, VITARENAL, SEVELAMER HYDROCHLORIDE, INSULIN AXTRAPH, SAROTEN, MIMPARA. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Apr 27, 2006. Female patient, 80 years of age, weighting 152.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: sepsis. ZEMPLAR dosage: unknown. During the same period patient was treated with DIGITOXIN, ISOSORBIDE MONONITRATE, CALCIUM CARBONATE, ANTIPHOSPHATE. Patient died on 11/03/2005.

Physician from GERMANY reported ZEMPLAR problem on Aug 11, 2006. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood parathyroid hormone increased, blood phosphorus increased, cardiac failure, pulmonary congestion, shock, unevaluable event. ZEMPLAR dosage: unknown. During the same period patient was treated with FUROSEMIDE, ALUMINIUM HYDROXIDE GEL, VERAPAMIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 05/12/2006.

ZEMPLAR problem was reported by a Physician from GERMANY on Aug 11, 2006. Male patient, weighting 183.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood calcium increased, blood phosphorus increased. ZEMPLAR dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, ASPIRIN, ENALAPRIL, CANDESARTAN CILEXETIL, BUDIAIR, MIMPARA. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on Aug 28, 2006. Male patient, 46 years of age, weighting 271.2 lb, was diagnosed with hyperparathyroidism secondary, diabetes mellitus and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: cardiac failure, diabetic gangrene, hepatic failure, sepsis. ZEMPLAR dosage: unknown. During the same period patient was treated with PHOSPHOSORB, CALCITRIOL, COLECALCIFEROL, NPH INSULIN, DIGITOXIN, FOLIC ACID, LIPIDIL, METOPROLOL SUCCINATE. Patient was hospitalized. Patient died on 11/07/2005.

ZEMPLAR problem was reported by a Physician from GERMANY on Aug 07, 2006. Female patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: shunt occlusion. ZEMPLAR dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on Sept 06, 2006. Female patient, weighting 130.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: gastroenteritis. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from CZECH REPUBLIC on Sept 05, 2006. Male patient, weighting 178.6 lb, was diagnosed with hyperparathyroidism secondary, hypercholesterolaemia, hypertension, insomnia, haemodialysis and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, pulmonary oedema. ZEMPLAR dosage: unknown. During the same period patient was treated with TORVACARD, TENOLOC, NITRENDIPINE, ZOREM, FUROSEMIDE, ALLOPURINOL, DIAZEPAM, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on May 22, 2006. Male patient, weighting 162.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: haematuria, renal haemorrhage. ZEMPLAR dosage: unknown. During the same period patient was treated with CALCIUM ACETATE, DECOSTRIOL, VITARENAL, BICA NORM, ASPIRIN, DIGITOXIN, DELIX PROTECT, CARVEDILOL. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from VENEZUELA on Sept 11, 2006. Female patient, 58 years of age, weighting 141.1 lb, was diagnosed with hyperparathyroidism secondary, vitamin supplementation, anaemia and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome. ZEMPLAR dosage: unknown. During the same period patient was treated with BENUTREX, ERYTHROPOYETIN, FOLIC ACID. Patient died on 09/05/2006.

Physician from GERMANY reported ZEMPLAR problem on Sept 13, 2006. Male patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: aortic stenosis, hypercalcaemia. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient died on 09/04/2006.

ZEMPLAR problem was reported by a Physician from GERMANY on Aug 05, 2006. Male patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, renal failure, hypertension and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: shunt occlusion. ZEMPLAR dosage: unknown. During the same period patient was treated with FUROSEMIDE, RAMIPRIL, ALFACALCIDOL. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on Sept 18, 2006. Male patient, weighting 156.5 lb, was diagnosed with renal disorder, coronary artery disease, renal failure, uraemic gastropathy and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased. ZEMPLAR dosage: unknown. During the same period patient was treated with CARVEDILOL, RAMIPRIL, CORVATON RETARD, ASPIRIN, HYDROCHLOROTHIAZDE, FUROSEMIDE, CALCIUM ACETATE, PANTOPRAZOLE. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Sept 18, 2006. Male patient, weighting 149.9 lb, was diagnosed with renal disorder, hypertension, coronary artery disease, renal failure chronic, goitre, polyneuropathy and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: large intestine perforation, peritonitis. ZEMPLAR dosage: unknown. During the same period patient was treated with CANDESARTAN CILEXETIL, CARVEDILOL, AMLODIPINE BESYLATE, ASPIRIN, VITARENAL, CALCIUM ACETATE, LEVOTHYROXINE, VALORON N. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported ZEMPLAR problem on Sept 11, 2006. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: cardiac failure, confusional state, hypercalcaemia, psychotic disorder. ZEMPLAR dosage: unknown. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Sept 06, 2006. Female patient, weighting 130.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: gastroenteritis. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from SPAIN reported ZEMPLAR problem on June 12, 2006. Male patient, 74 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, anaemia, hypertension, benign prostatic hyperplasia and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, blood bilirubin increased, cholestasis, colon cancer, gamma-glutamyltransferase increased, metastases to liver, metastases to lung, tumour marker increased. ZEMPLAR dosage: unknown. During the same period patient was treated with ASPOL, ATENOLOL, NASTICAL, TAMSULOSIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

ZEMPLAR problem was reported by a Physician from GERMANY on Sept 19, 2006. Male patient, weighting 191.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, circulatory collapse, coronary artery stenosis. ZEMPLAR dosage: unknown. Patient was hospitalized. Patient died on 09/13/2006.

Physician from SLOVAKIA (Slovak Republic) reported ZEMPLAR problem on June 12, 2006. Male patient, 40 years of age, weighting 191.8 lb, was diagnosed with hypertension and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: arthralgia. ZEMPLAR dosage: unknown. During the same period patient was treated with FUROSEMIDE, RAMIPRIL, METOPROLOL TARTRATE, ASPIRIN, KETOSTERIL, METHYLPREDNISOLONE, ISOSORBIDE DINITRATE. Patient recovered.

Showing 1-75 of 250 Next >

Ask Our Patient Community about ZEMPLAR

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant